Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)

NCT02495519 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT02495519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02495519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)
Lead sponsor
Yonsei University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2014
Completion date
June 30, 2018
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromatosis